Industry 4.0 meets pharma

● In 2022, Triastek’s and Siemens China signed a collaboration agreement to provide digital technologies for the global pharmaceutical industry. Combining Triastek’s 3D printing and digital pharmaceutical technologies and Siemens’ expertise in automation and digitisation is expected to lead to innovative and transformative solutions for the development and manufacturing of pharmaceuticals

● In 2022, Singapore’s MiRXES opened

Southeast Asia’s first industry 4.0 IVD (in vitro diagnostics) manufacturing facility in Singapore

● In 2021, UK’s GlaxoSmithKline is one of the first pharmaceutical companies to announce a digital twin initiative. Partnering with

Siemens and Atos, GSK has created a real-time simulation of the entire vaccine manufacturing process

● In 2021, Boehringer Ingelheim announced it is rolling out cutting-edge tech at the Vienna plant, from virtual reality and automation to digital twins and artificial intelligence.

● In 2020, US’ Merck teamed up with Siemens to digitise its manufacturing processes with the objective to automate its modular production and advance pharma’s 4.0 movement

● In 2019, India based ACG Group opened industry 4.0 centre of excellence in Switzerland